Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP222-AWP222, February 1, 2024. Introduction:Moyamoya is a progressive cerebrovascular disease characterized by stenosis of the cerebral arteries in the anterior circulation and less often the posterior circulation. At time of diagnosis 16 children (67%) had basilar artery stenosis.

Stenosis 40

Stenosis Sickle Cell Disease Cerebrovascular Disease Pediatrics 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP220-ATP220, February 1, 2025. Background:The uneven distribution of intracranial atherosclerotic stenosis (ICAS) along the internal carotid artery (ICA) had been described in early clinicopathological studies, yet related, large-scale data is lack despite the widespread utilization of angiography.

Stenosis 40

Stenosis Hospital Atherosclerosis Risk Factors 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWMP94-AWMP94, February 1, 2025. National Inpatient Sample (NIS) database from 2009 to 2020, evaluating patients who presented with stroke from ICAD and were treated with angioplasty and stenting and analyzed presenting co-morbidities and patient outcomes. vs 7.9%), diabetes (33.6%

Stents 40

Stents Stent Inpatient Angioplasty 40

Stroke: Vascular and Interventional Neurology

SEPTEMBER 13, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue 6 , November 1, 2023. Early stroke (within 30 days) occurred in 33 (31.7%) cases (31 cases in VA PAO and 2 cases in internal carotid PAO) with ischemic stroke (29 cases) comprising the largest group. PAO was successful in all cases.

Aneurysm 40

Aneurysm Stroke Strokes Stenosis 40

Cardiology Update

NOVEMBER 26, 2023

vs. 19.0%, p=0.57), as well as stroke at 30 days (2.0% The timing of redo-TAVR (whether performed before or after one year of the index TAVR) and the type of index transcatheter valve (balloon-expandable or non-balloon-expandable) did not significantly impact the rates of death or stroke after redo-TAVR.

TAVR 52

TAVR Aortic valve Outcomes Aortic 52

Circulation: Cardiovascular Interventions

OCTOBER 22, 2023

Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Circulation: Cardiovascular Interventions, Ahead of Print. Exposure of interest was PVD. Primary outcome was all-cause mortality. 2VB-PVD, HR 1.12; 95% CI, 1.09-1.15,

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

Society of Thoracic Surgeons - Congenital

OCTOBER 17, 2023

The study reviewed 42,586 patients who underwent low-risk isolated SAVR between 2011 and 2019 at 981 different cardiac surgery programs across the U.S. The most recent mid-term results from the PARTNER 3 and Evolut Low-Risk trials comparing risk of death and stroke from SAVR and TAVR are expected to be released in fall 2023.

Aortic valve 40

Aortic valve TAVR Aortic Cardiothoracic 40